Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.

Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody.

Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.

DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.

Matrix metalloproteinase-mediation of tumor targeting human recombinant tumor necrosis factor-α fusion protein.

Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.

Tumor necrosis factor-alpha in human milk.

Tumor necrosis factor in human disease.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro.

Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis.

Expression of arginase by mouse myeloid leukemic cell differentiation in vitro induced with tumor necrosis factor.

Role of plasminogen activator inhibitor on nephrotoxic nephritis and its modulation by tumor necrosis factor.

Recombinant human tumor necrosis factor-beta entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro.

Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo.

Recombinant mouse tumor necrosis factor expressed in mammalian cells: effect of glycosylation on cytotoxic activity.

Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro.

A regulatory role for tumor necrosis factor (TNF) in ML-1 human myeloblastic leukemia cell maturation.

Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis.

In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cells.

Recombinant human tumor necrosis factor enhances radiosensitivity and improves animal survival in murine neuroblastoma.

Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-alpha in the rat.

Shedding of tumor necrosis factor receptors by activated human neutrophils.

Effect of pyridoxine on tumor necrosis factor activities in vitro.

Suggest Documents

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.

Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody.

Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.

DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.

Matrix metalloproteinase-mediation of tumor targeting human recombinant tumor necrosis factor-α fusion protein.

Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.

Tumor necrosis factor-alpha in human milk.

Tumor necrosis factor in human disease.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro.

Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis.

Expression of arginase by mouse myeloid leukemic cell differentiation in vitro induced with tumor necrosis factor.

Role of plasminogen activator inhibitor on nephrotoxic nephritis and its modulation by tumor necrosis factor.

Recombinant human tumor necrosis factor-beta entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro.

Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo.

Recombinant mouse tumor necrosis factor expressed in mammalian cells: effect of glycosylation on cytotoxic activity.

Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro.

A regulatory role for tumor necrosis factor (TNF) in ML-1 human myeloblastic leukemia cell maturation.

Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis.

In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cells.

Recombinant human tumor necrosis factor enhances radiosensitivity and improves animal survival in murine neuroblastoma.

Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-alpha in the rat.

Shedding of tumor necrosis factor receptors by activated human neutrophils.

Effect of pyridoxine on tumor necrosis factor activities in vitro.

Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.

Recommend Documents

Follow Us